Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone

被引:94
作者
Bhardwaj, Upkar [1 ]
Burgess, Diane J. [1 ]
机构
[1] Univ Connecticut, Sch Pharm, Unit 3092, Storrs, CT 06269 USA
关键词
Extruded and non-extruded liposomes; Physicochemical properties; In vitro release; Hydrophobic drug; Dexamethasone; Sustained delivery; DIFFERENTIAL SCANNING CALORIMETRY; IN-VITRO RELEASE; DELIVERY SYSTEMS; INCORPORATING LIPOSOMES; PHASE-TRANSITIONS; LIPID-COMPOSITION; VIVO; CHOLESTEROL; STABILITY; MICROSPHERES;
D O I
10.1016/j.ijpharm.2010.01.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The physicochemical and release properties of non-extruded 'multilamellar' and small sonicated and extruded 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) liposomes containing hydrophobic drug dexamethasone were investigated. Non-extruded liposomes had similar diameter, however dexamethasone encapsulation decreased with increase in lipid chain length. Dexamethasone destabilized the liposome membranes as indicated by decrease in enthalpy and increase in the peak width of the main transition. Based on calorimetric analysis, it appeared that dexamethasone and cholesterol were heterogeneously distributed in the non-extruded liposomes. Sonication and extrusion reduced the diameter (DSPC > DPPC > DMPC) and decreased drug encapsulation (approximately 50%). Cholesterol incorporation decreased drug encapsulation in both extruded and non-extruded DMPC liposomes which appeared to be due to structural similarities between cholesterol and dexamethasone. Incorporation of dexamethasone and cholesterol in the same DMPC liposomes caused a marked perturbation in the phase transition. Dexamethasone release from extruded liposomes was fast, while non-extruded liposomes showed slower release. Release was fastest from DMPC liposomes and slowest from liposomes of high phase transition lipid DSPC. Incorporation of cholesterol did not decrease release from DMPC liposomes. These results indicated that change in the physicochemical properties and the phase transition behavior of liposomes, due to processing as well as incorporation of hydrophobic drug dexamethasone, changed their release properties. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 50 条
[1]   Studies on the formulation and in vitro release of ophthalmic liposomes containing dexamethasone sodium phosphate [J].
AlMuhammad, J ;
Ozer, AY ;
Hincal, AA .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (02) :123-130
[2]   In-vivo studies on dexamethasone sodium phosphate liposomes [J].
AlMuhammed, J ;
Ozer, AY ;
Ercan, MT ;
Hincal, AA .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (03) :293-305
[3]   LIPOSOME-INCORPORATED DEXAMETHASONE PALMITATE INHIBITS IN-VITRO LYMPHOCYTE-RESPONSE TO MITOGEN [J].
BENAMEUR, H ;
LATOUR, N ;
SCHANDENE, L ;
VANVOOREN, JP ;
FLAMION, B ;
LEGROS, FJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (10) :812-817
[4]   THE USE OF DIFFERENTIAL SCANNING CALORIMETRY AS A TOOL TO CHARACTERIZE LIPOSOME PREPARATIONS [J].
BILTONEN, RL ;
LICHTENBERG, D .
CHEMISTRY AND PHYSICS OF LIPIDS, 1993, 64 (1-3) :129-142
[5]   FATE OF DIFFERENT KINDS OF LIPOSOMES CONTAINING DEXAMETHASONE PALMITATE AFTER INTRAARTICULAR INJECTION INTO RABBIT JOINTS [J].
BONANOMI, MH ;
VELVART, M ;
WEDER, HG .
JOURNAL OF MICROENCAPSULATION, 1987, 4 (03) :189-200
[6]   Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage [J].
Cevc, G ;
Blume, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1663 (1-2) :61-73
[7]  
Cevc G., 1993, Liposome Technology, V1, P1
[8]  
Chidambaram N, 1999, AAPS PHARMSCI, V1
[9]   Aortic drug delivery of dexamethasone palmitate incorporated into lipid microspheres and its antiatherosclerotic effect in atherogenic mice [J].
Chono, S ;
Tauchi, Y ;
Morimoto, K .
JOURNAL OF DRUG TARGETING, 2005, 13 (07) :407-414
[10]   Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice [J].
Chono, S ;
Tauchi, Y ;
Deguchi, Y ;
Morimoto, K .
JOURNAL OF DRUG TARGETING, 2005, 13 (04) :267-276